Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | DPI Research Published a New Report on China In Vitro Diagnostics MarketThe research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data.
By: DPI Research Long–term Outlook: The China In Vitro Diagnostics Market is expected to reach more than US$ 10 Billion by 2021 with strong double digit growth rate from 2016 to 2021. China IVD Market: Segment wise Outlook Immunoassay has emerged as a significant rapidly growing market segment in China IVD market. Immunoassay test controls nearly XX% market share by the year 2021. Other segments such as Clinical Chemistry, Molecular testing and POCT are poised to be remarkable expansion in the near future. Growing demand for infectious disease testing, chronic disease testing and diagnosis in early stages of disease will usher the China IVD market. China IVD Market: Companies wise Outlook Roche is the leading company with more than XX% market share in the China IVD market and is expected to hold its strong position in the market. Sysmex Corporation and Abbott Laboratories are the other top two players in the China IVD market. Mindray and Shanghai Kehua Bioengineering( The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market, market segments, company wise sales analysis, regulation, major distributors and laboratories of IVD and outlook of the Chinese IVD companies. This report titled "China In Vitro Diagnostics( 1. Market and Forecast (2010 – 2021) 2. Segment Wise Market and Forecast (2010 – 2021) 3. Company Wise IVD Sales and Forecast (2010 – 2021) 4. Regulation and its Latest Development 5. Future Prospects in Attractive In Vitro Diagnostics Segments 6. Regional Trends and Opportunities 7. Main Participants/ 8. Major IVD Product Companies Outlook 9. Major Private Clinical Labs and Diagnostic Services Companies Outlook 10.Market Growth Drivers and Challenges The following segments of the China In Vitro Diagnostics market are detailed with size and six year forecast. Clinical Chemistry Immunoassay Molecular Testing Self–Monitoring of Blood Glucose (SMBG) Point of Care Testing (POCT) Hematology Coagulation Microbiology The following companies of the China In Vitro Diagnostics market are detailed with size and six year forecast Roche Diagnostics Abbott Laboratories Mindray Medical International Limited Sysmex Corporation Shanghai Kehua Bio–Engineering Co. Ltd. Other Companies The following Chinese companies of the China In Vitro Diagnostics market are detailed with company overview and its product portfolio Mindray Medical International Limited Shanghai Fosun Pharmaceutical Group Mingyuan Medicare Da An Gene Co. Ltd. Shanghai Kehua Bio–Engineering Co. Ltd. Zhejiang D.a. Diagnostics Technology Co., Ltd ADICON Clinical Laboratories Guangzhou Kingmed Diagnostics Center Co. Ltd. Kindstar Global BGI – Shenzhen OriGene Technologies For More Details: http://www.dpiresearch.com/ End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|